Foreign Bonds, Fres...
Health Care: Drugs
Infinity Pharmaceuticals Inc. (INFI: NASDAQ)
$25.13 -0.48 | -1.87%
05/21/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -53.96M | -40.04M | -48.98M | -32.51M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | -107.31K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 218.00K | -218.19K | 0.00 | 7.41M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 313.00K | 1.36M | 11.76M | -4.38M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -38.89M | -4.78M | -3.65M | 15.20M |
| Other Non-Cash Items | 9.93M | 5.51M | 8.27M | 7.11M |
| Net Cash From Continuing Operations | -80.14M | -33.11M | -26.59M | -4.76M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -80.14M | -33.11M | -26.59M | -4.76M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 79.26K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 138.44M | 233.52M | 161.52M |
| Purchases of Property, Plant & Equipment | -1.30M | -1.54M | -1.95M | -2.53M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | -150.59M | -201.09M | -166.57M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -62.00M | -13.69M | 30.48M | -7.50M |
| Issuance of Debt | 0.00 | 50.00M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 293.68M | 582.00K | 224.80K | 12.03M |
| Repayment of Long-Term Debt | 0.00 | -5.49K | -16.46K | -65.95K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 26.64K | 0.00 |
| Net Cash From Financing Activities | 293.68M | 50.58M | 234.98K | 11.97M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 151.54M | 3.78M | 4.13M | -287.32K |
Portfolios with INFI
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- Contributor8 Health Care Stocks With R...
Latest INFI Headlines from TheStreet
- Quick Take: The Next Big Thing in Biotech 05.17.13 | 10:05 am
- Biotech's Next Big Thing ASCO II
05.16.13 | 02:05 pm - Infinity Pharmaceuticals (INFI) Shares Cross Below 200 DMA 05.16.13 | 11:05 am
- ASCO '13 Preview: Gilead's Big Cancer Debut 05.15.13 | 06:05 pm
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- Biotech's Next Big Thing: ASCO 05.09.13 | 09:05 am
- Infinity Pharmaceuticals Enters Oversold Territory (INFI) 05.08.13 | 12:05 pm
- Top Insider Trades: NAV, TXI, INFI, AGCO 04.17.13 | 09:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
Press Releases for INFI
- Infinity To Present At The 25th Annual Roth Conference - Business Wire 03.11.13 | 08:03 am
- Infinity Provides Company Update And Reports Full-Year 2012 Financial Results - Business Wire 03.05.13 | 04:03 pm
- Infinity To Present At Upcoming Conferences - Business Wire 02.25.13 | 08:02 am
- Infinity Announces The Date Of Its Full-Year 2012 Financial Results Conference Call And Webcast - Business Wire 02.19.13 | 08:02 am
- Infinity To Participate In Three Conferences In February - Business Wire 02.06.13 | 08:02 am
- Infinity Provides Key 2013 Goals And Financial Guidance - Business Wire 01.07.13 | 08:01 am
- Infinity To Present At The J.P. Morgan Annual Healthcare Conference - Business Wire 12.31.12 | 08:12 am
- Infinity Amends PI3K-Delta,Gamma Agreement With Millennium - Business Wire 12.24.12 | 08:12 am
- Infinity Announces Closing Of Public Offering And Exercise Of Over-Allotment Option - Business Wire 12.18.12 | 10:12 am
- Infinity Prices Public Offering Of Common Stock - Business Wire 12.13.12 | 09:12 am
Partner Headlines for INFI
- Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ - NASDAQ 04.11.13 | 12:04 pm
- These Stocks Are On Winning Streaks, But Short Sellers Aren't Optimistic - Seeking Alpha 01.09.13 | 09:01 am
- Infinity Pharma RESTRUCTURES Alliance with Mundipharma and 4 Stocks Hiting 52-Week Highs - Wall St. Cheat Sheet 07.19.12 | 09:07 am
- Morning Market Losers - Benzinga 06.18.12 | 09:06 am
- Ultimate Market Recap: Body Central Sinks 47%, Facebook Buys Face.com - Wall St. Cheat Sheet 06.18.12 | 08:06 am
- Body Central CRASHES 47% and 4 Hot Stocks in the Crosshairs - Wall St. Cheat Sheet 06.18.12 | 03:06 am
- Noteworthy Institutional 5% Ownership Filings On Friday - Seeking Alpha 04.02.12 | 08:04 am
- AACR Annual Oncology Meeting: A Look Into Various Abstracts - Seeking Alpha 03.27.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Company News for January 30, 2012 - Corporate Summary - Zacks 01.30.12 | 10:01 am
